Prostate Cancer Brain Metastases (Bern, Nat Commun. 2022)

Summary

Prostate Cancer Brain Metastases (Bern, Nat Commun. 2022) is a study catalogued by cBioPortal DataHub under the cancer-type code prostate. EvidenceHelix groups it with prostate studies.

Study description

Prostate Cancer Brain Metastases, Switzerland. Dataset was generated in 2019 by Antonio Rodriguez, John Gallon, Salvatore Piscuoglio and Mark Rubin.

Text as published in the source's study metadata.

Citation & PubMed

Rodriguez-Calero et al. Nat Commun. 2022

Linked PubMed records: PMID 35504881

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

prostate_pcbm_swiss_2019

Short name

PCBM (Bern 2019)

Source cancer-type code

prostate

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Rodriguez-Calero et al. Nat Commun. 2022

• PubMed record 35504881 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Prostate Cancer (DKFZ, Cancer Cell 2018)

  Whole genome and transcriptome sequencing of tumor/normal pairs from 292 prostate cancer patients.

  ProstateOther published and consortium studiesSource code prostatePubMed 1

• Prostate Cancer MDA PCa PDX (MD Anderson, Clin Cancer Res 2024)

  Targeted sequencing and whole-genome sequencing of 88 MD Anderson Prostate Cancer PDX models derived from 38 patients with tumor.

  ProstateOther published and consortium studiesSource code prostatePubMed 1

• The Metastatic Prostate Cancer Project (Provisional, June 2021)

  The Metastatic Prostate Cancer Project is a patient-driven initiative. This study includes genomic data, cfDNA tumor fractions, patient-reported data (pre-pended as PRD), medical record data (MedR), and pathology repo…

  ProstateOther published and consortium studiesSource code prostate

• Prostate Cancer (MSK, Cell Metab 2020)

  MSK-IMPACT Sequencing of 18 prostate cancer tumor/normal pairs.

  ProstateMSK studiesSource code prostatePubMed 1

• Prostate Cancer (MSK, Clin Cancer Res 2024)

  Targeted sequencing of 2,257 prostate cancer patient samples and their matched normals via MSK-IMPACT platform. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licen…

  ProstateMSK studiesSource code prostatePubMed 1

• Metastatic Prostate Adenocarcinoma (MCTP, Nature 2012)

  Exome sequencing of 61 prostate cancer tumor/normal pairs (50 metastatic CRPCs and 11 high-grade localized prostate cancers). Generated by Arul Chinnaiyan's and Scott Tomlins' labs at the University of Michigan.

  ProstateOther published and consortium studiesSource code pradPubMed 1

• Metastatic Prostate Adenocarcinoma (SU2C/PCF Dream Team, PNAS 2019)

  Whole exome sequencing of 444 castrate resistant prostate cancer tumor/normal pairs. SU2C-PCF Dream Team: Precision Therapy for Advanced Prostate Cancer.

  ProstateOther published and consortium studiesSource code pradPubMed 1

• Metastatic Prostate Cancer (SU2C/PCF Dream Team, Cell 2015)

  Whole-exome sequencing of 150 metastatic prostate cancer tumor/normal pairs by the SU2C/PCF Dream Team.

  ProstateOther published and consortium studiesSource code pradPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.